Hong Kong United Oncology Center

Kowloon

0 studies enrolling now · 3 studies all time

What they study most

EGFR Exon 20 Insertion Mutation, ERBB Fusion, HER2-activating Mutation, Metastatic Solid Tumor, NRG1 Fusion, NSCLC Stage IIIB, NSCLC, Recurrent, NSCLC, Stage IIIC, NSCLC, Stage IV, Non-small Cell Lung Cancer

Studies at this site

• Study of Sacituzumab Govitecan in Participants With Metastatic Solid Tumors — Running, not enrolling
• Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) — Running, not enrolling
• Study of Tarloxotinib in Pts With NSCLC (EGFR Exon 20 Insertion, HER2-activating Mutations) & Other Solid Tumors With NRG1/ERBB Gene Fusions — Stopped early